Tags: human dna modification | gene therapy | beta thalassaemia

Report: Europe OKs Human DNA Modification for First Time

Report: Europe OKs Human DNA Modification for First Time
(Dreamstime)

By    |   Sunday, 15 April 2018 03:21 PM

European regulators have approved a trial for DNA-splicing therapy to treat a blood disorder, paving the way for genetic modification of humans for the first time, according to the U.K.'s Daily Mail on Sunday.

The trial will be used to treat the blood disorder "beta thalassaemia," which attacks the production of hemoglobin, a protein which facilitates transporting oxygen in blood.

Biotech company Crispr Therapeutics' scientists hope altering a body's genetic code can stop the mutation and "restore healthy levels of hemoglobin," according to the report.

"We will look back and think that this is the real beginning of gene therapy," professor Robin Lovell-Badge told The Telegraph, U.K.

A similar medical trial has already been underway in China, according to the report.

© 2018 Newsmax. All rights reserved.

   
1Like our page
2Share
Newsfront
European regulators have approved a trial for DNA-splicing therapy to treat a blood disorder, paving the way for genetic modification of humans for the first time, according to the U.K.'s Daily Mail on Sunday.The trial will be used to treat the blood disorder "beta...
human dna modification, gene therapy, beta thalassaemia
121
2018-21-15
Sunday, 15 April 2018 03:21 PM
Newsmax Media, Inc.
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved